Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Dyslipidemia

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 36 articles: HTML format

Single Articles

May 2025
1. BIAGETTI B, Cordero Asanza E, Perez-Lopez C, Araujo-Castro M, et al
   Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study.
   J Clin Endocrinol Metab. 2025;110:e1811-e1820.
   PubMed     Abstract available
   
   
   
2. LV Z, Fu Y, Ma Y, Liu C, et al
   Associations Between Visceral and Liver Fat and Cardiac Structure and Function: A UK Biobank Study.
   J Clin Endocrinol Metab. 2025;110:e1856-e1865.
   PubMed     Abstract available
   
   
   April 2025
3. ZHENG X, Zhao D, Wang L, Wang Y, et al
   Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents.
   J Clin Endocrinol Metab. 2025;110:e1458-e1465.
   PubMed     Abstract available
   
   
   
4. LIAO Z, Wang J, Chen Y, Li W, et al
   Associations of Body Mass Index Growth Rates and Body Composition With Cardiometabolic Risks in Chinese Preschool Children.
   J Clin Endocrinol Metab. 2025;110:e1439-e1450.
   PubMed     Abstract available
   
   
   
5. LOH WJ, Chan DC, Pang J, Hooper AJ, et al
   Opportunistic Detection of Phytosterolemia During Genetic Testing for FH: Case Series and Contextual Review.
   J Clin Endocrinol Metab. 2025;110:1358-1364.
   PubMed     Abstract available
   
   
   March 2025
6. SPAGNUOLO CM, Wang J, McIntyre AD, Kennedy BA, et al
   Comparison of Patients With Familial Chylomicronemia Syndrome and Multifactorial Chylomicronemia Syndrome.
   J Clin Endocrinol Metab. 2025;110:1158-1165.
   PubMed     Abstract available
   
   
   
7. CHEN LM, Valentine A, Davis SM, Graber E, et al
   Multicenter Analysis of Cardiometabolic-Related Diagnoses in Youth With Congenital Adrenal Hyperplasia: A PEDSnet Study.
   J Clin Endocrinol Metab. 2025;110:e1009-e1016.
   PubMed     Abstract available
   
   
   February 2025
8. TRICO D, Rebelos E, Astiarraga B, Baldi S, et al
   Effects of Hypertriglyceridemia With or Without NEFA Elevation on beta-cell Function and Insulin Clearance and Sensitivity.
   J Clin Endocrinol Metab. 2025;110:e667-e674.
   PubMed     Abstract available
   
   
   
9. PAQUETTE M, Trinder M, Guay SP, Brunham LR, et al
   Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic Criteria.
   J Clin Endocrinol Metab. 2025;110:e703-e709.
   PubMed     Abstract available
   
   
   January 2025
10. CLAAHSEN-VAN DER GRINTEN HL, Adriaansen BPH, Falhammar H
    Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    J Clin Endocrinol Metab. 2025;110.
    PubMed     Abstract available
    
    
    
11. KIM S, Subramanian S
    Approach to Lipid Management in the Patient with Diabetes.
    J Clin Endocrinol Metab. 2025 Jan 11:dgaf018. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2024
12. BOLLIG KJ, Barnhart KT, Schisterman EF, Johnstone EB, et al
    The Association of Female and Male Preconception Dyslipidemia With Live Birth in Couples Seeking Fertility Treatment.
    J Clin Endocrinol Metab. 2024;110:91-101.
    PubMed     Abstract available
    
    
    
13. TAVAGLIONE F, Marafioti G, Romeo S, Jamialahmadi O, et al
    Machine Learning Reveals the Contribution of Lipoproteins to Liver Triglyceride Content and Inflammation.
    J Clin Endocrinol Metab. 2024;110:218-227.
    PubMed     Abstract available
    
    
    
14. BARETELLA O, Blum MR, Abolhassani N, Alwan H, et al
    Associations between subclinical thyroid dysfunction and cardiovascular risk factors according to age and sex.
    J Clin Endocrinol Metab. 2024 Dec 12:dgae860. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2024
15. GUAY SP, Paquette M, Blais C, Fortin A, et al
    High hsCRP Concentration Is Associated With Acute Pancreatitis in Multifactorial Chylomicronemia Syndrome.
    J Clin Endocrinol Metab. 2024;109:e2255-e2260.
    PubMed     Abstract available
    
    
    October 2024
16. DAIANA I, Didac L, Celia RB, Natalia A, et al
    The Lipoprotein Profile Evaluated by 1H-NMR Improves the Performance of Genetic Testing in Familial Hypercholesterolemia.
    J Clin Endocrinol Metab. 2024;109:e2090-e2099.
    PubMed     Abstract available
    
    
    September 2024
17. MARCHESAN LB, da Silva TR, Spritzer PM
    Topiramate added to metformin for obesity control in women with polycystic ovary syndrome: a randomized clinical trial.
    J Clin Endocrinol Metab. 2024 Sep 14:dgae637. doi: 10.1210.
    PubMed     Abstract available
    
    
    
18. PAQUETTE M, Trinder M, Guay SP, Brunham LR, et al
    Predictors of cardiovascular disease in individuals with dysbetalipoproteinemia: a prospective study in the UK Biobank.
    J Clin Endocrinol Metab. 2024 Sep 7:dgae618. doi: 10.1210.
    PubMed     Abstract available
    
    
    August 2024
19. YANG C, Ji L, Han X
    Low C reactive protein-alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease: a Meta-analysis.
    J Clin Endocrinol Metab. 2024 Aug 30:dgae602. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2024
20. ZHAI X, Li Y, Teng X, Teng W, et al
    Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults.
    J Clin Endocrinol Metab. 2024 Jul 2:dgae387. doi: 10.1210.
    PubMed     Abstract available
    
    
    June 2024
21. SANTOS RD
    Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening.
    J Clin Endocrinol Metab. 2024;109:e1544-e1545.
    PubMed    
    
    
    
22. AGBAJE AO
    Associations of Sedentary Time and Physical Activity From Childhood With Lipids: A 13-Year Mediation and Temporal Study.
    J Clin Endocrinol Metab. 2024;109:e1494-e1505.
    PubMed     Abstract available
    
    
    February 2024
23. MAGNO S, Ceccarini G, Corvillo F, Pelosini C, et al
    Clinical Characteristics of Patients With Acquired Partial Lipodystrophy: A Multicenter Retrospective Study.
    J Clin Endocrinol Metab. 2024;109:e932-e944.
    PubMed     Abstract available
    
    
    
24. HEDEGAARD BS, Nordestgaard BG, Kanstrup HL, Thomsen KK, et al
    High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics.
    J Clin Endocrinol Metab. 2024;109:659-667.
    PubMed     Abstract available
    
    
    
25. BESCI O, Foss de Freitas MC, Guidorizzi NR, Guler MC, et al
    Deciphering the Clinical Presentations in LMNA-related Lipodystrophy: Report of 115 Cases and a Systematic Review.
    J Clin Endocrinol Metab. 2024;109:e1204-e1224.
    PubMed     Abstract available
    
    
    
26. U-DIN M, Ahmed BA, Syed SA, Ong FJ, et al
    Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
    J Clin Endocrinol Metab. 2024;109:680-690.
    PubMed     Abstract available
    
    
    January 2024
27. PARK SY, Jun JE, Jeong IK, Ahn KJ, et al
    Comparison of the Efficacy of Ezetimibe Combination Therapy and High-Intensity Statin Monotherapy in Type 2 Diabetes.
    J Clin Endocrinol Metab. 2024 Jan 4:dgad714. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2023
28. ALVAREZ-JIMENEZ L, Morales-Palomo F, Moreno-Cabanas A, Ortega JF, et al
    Acute Statin Withdrawal Does not Interfere With the Improvements of a Session of Exercise in Postprandial Metabolism.
    J Clin Endocrinol Metab. 2023;109:80-91.
    PubMed     Abstract available
    
    
    November 2023
29. LI S, Cui M, Liu Y, Liu X, et al
    Metabolic profiles of type 2 diabetes and their association with renal complications.
    J Clin Endocrinol Metab. 2023 Nov 2:dgad643. doi: 10.1210.
    PubMed     Abstract available
    
    
    October 2023
30. HIRSCHBERG AL
    Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?
    J Clin Endocrinol Metab. 2023 Oct 27:dgad590. doi: 10.1210.
    PubMed     Abstract available
    
    
    September 2023
31. MEYER EJ, Wittert GA
    Approach the patient with obstructive sleep apnea and obesity.
    J Clin Endocrinol Metab. 2023 Sep 27:dgad572. doi: 10.1210.
    PubMed     Abstract available
    
    
    
32. TAO X, Liu L, Ma P, Hu J, et al
    Association of Circulating Very Long Chain Saturated Fatty Acids with Cardiovascular Mortality in NHANES 2015-2016.
    J Clin Endocrinol Metab. 2023 Sep 21:dgad561. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2023
33. CHEN JX, Geng T, Zhang YB, Wang Y, et al
    Associations of Clinical Risk Factors and Novel Biomarkers with Age at Onset of Type 2 Diabetes.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad422. doi: 10.1210.
    PubMed     Abstract available
    
    
    May 2023
34. GRIGORYAN S, Nhan W, Zhang L, Urban C, et al
    Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations.
    J Clin Endocrinol Metab. 2023;108:e343-e349.
    PubMed     Abstract available
    
    
    April 2023
35. SYED-ABDUL MM, Stahel P, Zembroski A, Tian L, et al
    Glucagon-like Peptide-2 Acutely Enhances Chylomicron Secretion in Humans Without Mobilizing Cytoplasmic Lipid Droplets.
    J Clin Endocrinol Metab. 2023;108:1084-1092.
    PubMed     Abstract available
    
    
    March 2023
36. NEWMAN CB, Tobert JA
    Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol.
    J Clin Endocrinol Metab. 2023;108:784-790.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.